ATE390937T1 - Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 - Google Patents

Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7

Info

Publication number
ATE390937T1
ATE390937T1 AT00950382T AT00950382T ATE390937T1 AT E390937 T1 ATE390937 T1 AT E390937T1 AT 00950382 T AT00950382 T AT 00950382T AT 00950382 T AT00950382 T AT 00950382T AT E390937 T1 ATE390937 T1 AT E390937T1
Authority
AT
Austria
Prior art keywords
methods
mda
treating
human
hyperproliferative diseases
Prior art date
Application number
AT00950382T
Other languages
English (en)
Inventor
Abner Mhashilkar
Bob Schrock
Sunil Chada
Original Assignee
Introgen Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Introgen Therapeutics Inc filed Critical Introgen Therapeutics Inc
Application granted granted Critical
Publication of ATE390937T1 publication Critical patent/ATE390937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT00950382T 1999-07-15 2000-07-13 Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 ATE390937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14435499P 1999-07-15 1999-07-15
US20076800P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
ATE390937T1 true ATE390937T1 (de) 2008-04-15

Family

ID=26841928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00950382T ATE390937T1 (de) 1999-07-15 2000-07-13 Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7

Country Status (6)

Country Link
EP (1) EP1307234B1 (de)
AT (1) ATE390937T1 (de)
AU (1) AU6349400A (de)
CA (1) CA2379171A1 (de)
DE (1) DE60038508T2 (de)
WO (1) WO2001005437A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650303B1 (de) 1993-10-27 2008-05-28 The Trustees of Columbia University of the City of New York Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung
US5710137A (en) 1996-08-16 1998-01-20 The Trustees Of Columbia University In The City Of New York Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype
EP1404359A2 (de) * 2000-12-07 2004-04-07 Board Of Regents, The University Of Texas System Behandlungsverfahren mit menschlichem mda-7
US20030082140A1 (en) 2001-08-20 2003-05-01 Fisher Paul B. Combinatorial methods for inducing cancer cell death
EP1327688A1 (de) 2002-01-14 2003-07-16 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Adenoviren mit erhöhter Lysisfähigkeit
JP2005533000A (ja) * 2002-03-05 2005-11-04 ボード　オブ　リージェンツ，　ザ　ユニバーシティ　オブ　テキサス　システム Ｍｄａ−７に関与する免疫誘導を増強する方法
EP1578196A4 (de) * 2002-12-23 2006-04-12 Univ Columbia Mda-7 und freie radikale bei der krebsbehandlung
US8034790B2 (en) 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
EP2050458A1 (de) * 2007-10-17 2009-04-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL24 zur Induzierung des Zelltodes hyperproliferativer oder autoimmuner Zellen
US12454561B2 (en) 2018-03-19 2025-10-28 Multivir Inc. Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650303B1 (de) * 1993-10-27 2008-05-28 The Trustees of Columbia University of the City of New York Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung
BR9713632A (pt) * 1996-12-23 2000-04-11 Schering Corp Citocina de mamìfero relacionada com a il-10

Also Published As

Publication number Publication date
DE60038508D1 (de) 2008-05-15
WO2001005437A2 (en) 2001-01-25
DE60038508T2 (de) 2009-04-30
EP1307234B1 (de) 2008-04-02
CA2379171A1 (en) 2001-01-25
AU6349400A (en) 2001-02-05
WO2001005437A3 (en) 2003-02-06
EP1307234A2 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
Kawasaki et al. The mechanisms and evidence of efficacy of electrical stimulation for healing of pressure ulcer: a systematic review
Chang et al. Lymphangiogenesis new mechanisms
EP1692516A4 (de) Therapieverfahren
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
DE69737066D1 (de) Verwendung von activem vitamin d analoga zur behandlung von prostataerkrangkungen
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
ATE390937T1 (de) Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7
DE60230807D1 (de) Behandlung von sarkom bei menschen mit adenovirus-vektor tnf-alpha
ATE461707T1 (de) Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
DE50014532D1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60035035D1 (de) Injektion von autologem knochenmark in den herzmuskel
WO2002045737A3 (en) Methods of treatment involving human mda-7
DK1144600T3 (da) Akt-3-nukleinsyre, polypeptider og anvendelser deraf
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
EA200001124A1 (ru) Способ генной терапии
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
ATE447426T1 (de) Elektromagnetische stimulation bei patienten mit osteoporose
Katelaris et al. Electrical stimulation in the treatment of chronic venous ulceration
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
Trontelj et al. Treatment of chronic wounds by low frequency pulsed electrical current
ATE239492T1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
WO2003016343A3 (en) USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1307234

Country of ref document: EP